Abstract:Objective: This study discusses the therapeutic effect of high-dose urokinase treatment for hypertension ventricular hemorrhage. Methods: A total of 60 patients with hypertension ventricular hemorrhage were randomly assigned to two groups: treatment group (n = 30)and control group (n = 30). Both groups received bilateral external ventricular drain. The treatment group was injected with 50,000 IU urokinase to the lateral ventricle every day; the total injection volume per day was 100,000 IU. The control group was injected with 20,000 IU urokinase to the lateral ventricle every day with a total injection volume per day of 40,000 IU. Lumbar puncture was performed in both groups after the later ventricular drain was removed to release cerebrospinal fluid (CSF). Head Computed tomography(CT) examination was performed regularly to observe changes in the ventricular hematoma as well as the occurrence of complications such as intracranial infection and hydrocephalus. Patient prognosis 6 weeks after surgery was compared between the two groups. Results: In the treatment group, the intraventricular hemorrhage clearance time and the number of instances of urokinase treatment were significantly less than those of the control group (P<0.05). The total urokinase dosage of the treatment group was significantly higher than that of the control group (P<0.05). With respect to post-surgery complications, in the treatment group, there were three cases of hydrocephalus and one case of intracranial infection. In the control group, there were four cases of hydrocephalus and three cases of intracranial infection. Intraventricular re-hemorrhage was not observed in either group. Intracranial infection was relieved after strengthened anti-infective therapy and continuous drainage. There was a statistically significant difference in the occurrence of complications between the treatment group and the control group (P<0.05). The rate of good prognosis in the treatment group was higher than that of the control group (P<0.05), and the inefficiency rate was lower (P<0.05). Conclusions: High-dose urokinase treatment produces a significant therapeutic effect in hypertension ventricular hemorrhage. This treatment can quickly eliminate intraventricular hemorrhage, shorten the ventricular drain tube indwelling time, decrease the occurrence of intracranial infection, and increase the likelihood of a good prognosis.

Safety and Efficiency of Delayed Thrombolysis with Urokinase in the Treatment of Low Extremity Deep Venous Thrombosis

Safety and Efficacy of Low Dosage of Urokinase for Catheter-directed Thrombolysis of Deep Venous Thrombosis

A clinical study of high-dose urokinase for the treatment of the patients with hypertension induced ventricular hemorrhage

Comparison of Low-Molecular-weight-heparin and Unfractionated Heparin for Acute PTE

Catheter Directed Thrombolysis for Treatment of Acute Deep Venous Thrombosis of the Lower Extremity of the Effect and Safety Analysis in 116 Cases

Efficacy of percutaneous mechanical thrombus removal in acute lower extremity deep venous thrombosis

Study on the changes in the left ventricular diastolic function of the patients with acute myocardial infarction treated with the urokinase thrombolysis therapy within 3 hours or after 3 hours of attack

AngioJet Mechanical Thrombectomy for Lower Deep Venous Thrombosis

Catheter-directed Thrombolysis Compared with Anticoagulation Treatment for Acute Deep Venous Thrombosis-Short and Mid-Term Result

Clinical experience of thrombectomy and catheter-directed thrombolysis in the treatment of lower extremity deep vein thrombosis

Intra-arterial Contimuous Thrombolytic Therapy for Lower Extremity Deep Vein Thrombosis

TRANSCATHETER THROMBOLYSIS VIA THE SMALL SAPHENOUS VEIN FOR ACUTE LOWER LIMB DEEP VENOUS THROMBOSIS

Rapid pumping of urokinase in the catheter-directed thrombolysis for the management of acute deep vein thrombosis

Analysis of Efficacy of Therapy in 165 Cases of Deep Vein Thrombosis of Lower Extremity

Urokinase Combined with Liposomal Alprostadil in the Treatment of Acute Myocardial Infarction

Comparison of clear effect and the complications, and short and mid-term effects between ultrasound-guided and non-guided catheter-directed thrombolysis in the treatment of deep venous thrombosis of lower extremity

A case-controlled study on AngioJet rheolytic thrombectomy and catheter-directed thrombolysis in the treatment of acute lower extremity deep venous thrombosis

A systematic review and meta-analysis of the relative safety and efficacy of treating lower extremity deep vein thrombosis via pharmacomechanical thrombectomy and catheter-directed thrombolysis

Application of inferior vena cava filter placement and catheter-guided thrombolysis in treatment of deep venous thrombosis in lower extremities

Application evaluation of different approaches for catheter-directed thrombolysis in acute lower-extremity deep venous thrombosis

Long-term result of thrombectomy and thrombolysis for acute mixed deep vein thrombosis of the lower extremity